查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1235928

全球连续性肾臟替代疗法市场：到 2028 年的预测——按产品、方式、年龄组、最终用户和地区分类

Continuous Renal Replacement Therapy Market Forecasts to 2028 - Global Analysis By Product, Modality, Age Group, End User and Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球持续性肾臟替代疗法 (CRRT) 市场将在 2022 年达到 13.1 亿美元，到 2028 年达到 22.3 亿美元，预计在此期间以 9.3% 的复合年增长率增长预测期。

连续性肾臟替代疗法 (CRRT) 是急性肾损伤 (AKI) 重症患者的常用治疗方法，尤其是那些血流动力学不稳定的患者。 它涉及通过血液滤过、血液透析或两者结合从血液中去除溶质的过程。

根据美国医院协会的数据，2021 年将有 208 家联邦医院、625 家非联邦精神病医院和 5,141 家社区医院。 此外，由于AKI住院患者的显着增加和老年人口的增加，对CRRT系统的需求也在增加，这是市场扩张的驱动力。

市场动态

驱动程序

急性肾损伤和慢性肾病增加

急性肾功能衰竭的主要危险因素是糖尿病、高血压和衰老。 糖尿病的患病率在全球范围内迅速上升。 因此，随着糖尿病的流行，急性肾功能衰竭患者的数量也在增加。 医护人员意识的提高有望遏制急性肾损伤的发生，加强对老年人基础疾病的管理。

抑製剂

治疗费用高

新兴国家/地区的人们更喜欢购买低价商品，因为他们看重购买能力。 儘管发展中国家的成本很高，但许多人的低购买力使他们无法采取此类措施。 这限制了发达国家和发展中国家对该疗法的需求和采用。

机会

新技术介绍

设备设计的技术进步极大地促进了危重患者的治疗。 这些技术创新大大扩展了 ICU 体外治疗的范围。 此外，软件集成很可能成为最先进机器的全新工具。

威胁

严格的医疗保健法规

由于公司受制于许多现有的法律法规，它们很容易受到监管环境变化的影响，不合规很可能对其运营、财务状况和业务产生不利影响。 作为医疗保健行业的进入者，让贵公司的运营和产品受制于各种政府法规会阻碍市场扩张。

COVID-19 的影响

COVID-19 的总体影响对市场仍然是积极的。 大流行显着增加了全球对肾臟替代液的需求。 与过去的美国人口相比，COVID-19 患者对 RRT 的需求增加了五倍。 例如，在中国和意大利，据报导 AKI 发生率高达 29%（国际肾脏病学会研究 2020）。 及早实施连续性肾臟替代治疗 (CRRT) 对于降低 AKI 的发病率很重要，AKI 因 COVID-19 感染而增加。

连续静脉血液滤过疗法 (CVVHDF) 预计在预测期内将成为最大的细分市场

由于透析治疗的增加，估计连续静脉血液滤过 (CVVHDF) 部分有良好的增长。 这种治疗涉及全面去除和更换血液中的溶质和液体。 它还包括扩散和对流的原理，从而促进了市场的增长。

预计在预测期内，成年人的复合年增长率最高。

由于各种监管批准和新产品开发的增加，预计在预测期内成人将以最快的复合年增长率增长。 此外，不同市场参与者采用不同的增长策略也为该行业创造了有利可图的机会。

市场份额最高的地区

由于技术进步和医疗保健支出增加，亚太地区预计在预测期内将占据最大的市场份额。 这主要是由于加大了对产品研发的投入力度。 此外，主要製造商注重扩大地域分布也是推动该地区增长的一个因素。

复合年增长率最高的地区

由于老年人口增加和急性肾损伤增加，预计欧洲在预测期内的复合年增长率最高。 连续性肾臟替代疗法新技术的高采用率和完善的医疗基础设施的存在显着推动了该地区的市场增长。

市场主要公司

连续性肾臟替代疗法 (CRRT) 市场的主要参与者是： Asahi Kasei Corporation, B. Braun Medical Inc., Baxter International Inc., Chongqing Shanwaishan Science and Technology Co, Ltd., Fresenius Medical Care AG & Co.KGaA, Infomed SA, Medica SpA, Medical Components, Inc. , Medites Pharma Spol.S.R.O., Medtronic Plc, Nikkiso Co., Ltd., Ningbo Tianyi Medical Appliance Co., Ltd., NIPRO Corporation, NxStage Medical, Inc., Toray Medical Co., Ltd.

主要发展

2021 年 2 月，DaVita 通过将其安全的远程医疗平台 DaVita Care Connect 纳入其家庭透析计划，取得了第一名。 它是该公司服务套件中的一系列互联技术之一，旨在改善决定在家接受治疗的患者的治疗结果和护理体验。

2020 年 12 月，美敦力公司宣布推出 Carpe Diem Cardiac Renal Pediatric Dialysis Emergency Unit。 该程序适用于需要血液透析的急性肾损伤和体液超负荷的患者。 它将为体重在 2.5 至 10 公斤之间的患者提供持续性肾臟替代疗法 (CRRT)。

2020 年 4 月，全球透析产品和服务提供商 Fresenius Medical Care 宣布已发布咨询，呼吁在大流行危机期间为晚期慢性肾病患者提供临床护理原则。. 该咨询还指出，在 COVID-19 危机期间需要肾臟替代治疗的患者也应接受与其医生协商后确定的治疗。

我们的报告提供了什么

  • 区域和国家级细分市场的市场份额评估
  • 向新进入者提出战略建议
  • 2020、2021、2022、2025 和 2028 年的综合市场数据
  • 市场驱动因素（市场趋势、制约因素、机遇、威胁、挑战、投资机会/建议等）
  • 根据市场预测在关键业务领域提出战略建议
  • 竞争格局和趋势
  • 公司简介，包括详细的战略、财务状况和近期发展
  • 供应链趋势反映了最新的技术进步。

提供免费定制

购买此报告的客户将免费获得以下定制之一。

  • 公司简介
    • 其他市场公司的综合概况（最多 3 人）
    • 关键公司的 SWOT 分析（最多 3 人）
  • 区域细分
    • 应客户要求提供主要国家/地区的市场估算、预测和復合年增长率（注意：通过可行性检查）
  • 竞争基准

根据产品组合、地理分布和战略联盟对主要参与者进行基准测试

目录

第 1 章执行摘要

第二章前言

  • 概览
  • 利益相关者
  • 调查范围
  • 调查方法
    • 数据挖掘
    • 数据分析
    • 数据验证
    • 研究方法
  • 调查来源
    • 主要研究信息来源
    • 二手研究资源
    • 假设

第三章市场趋势分析

  • 司机
  • 约束因素
  • 机会
  • 威胁
  • 产品分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买家的议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第 5 章全球连续性肾臟替代疗法 (CRRT) 市场：按产品分类

  • 透析液和置换液
  • 一次性用品
  • 血液过滤器
  • 系谱套装和试管
  • CRRT系统
  • 其他产品

第 6 章全球连续性肾臟替代疗法 (CRRT) 市场：按方式分类

  • 低速连续超滤 (SCUF)
  • 连续静脉血液滤过 (CVVH)
  • 连续性静脉血液透析 (CVVHD)
  • 连续静脉血液透析滤过 (CVVHDF)

第 7 章全球持续性肾臟替代治疗 (CRRT) 市场：按年龄组分类

  • 成人
  • 儿科/新生儿科

第 8 章全球连续性肾臟替代疗法 (CRRT) 市场：按最终用户分类

  • 医院
  • 门诊中心
  • 专科诊所
  • 其他最终用户

第 9 章全球连续性肾臟替代疗法 (CRRT) 市场：区域

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 意大利
    • 法国
    • 西班牙
    • 其他欧洲
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 新西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中东和非洲
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 卡塔尔
    • 南非
    • 其他中东地区

第10章主要发展

  • 合同、伙伴关係、协作和合资企业
  • 收购与合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第11章公司简介

  • Asahi Kasei Corporation
  • B. Braun Medical Inc.
  • Baxter International Inc.
  • Chongqing Shanwaishan Science and Technology Co., Ltd.
  • Fresenius Medical Care AG & Co. KGaA
  • Infomed SA
  • Medica SpA
  • Medical Components, Inc.
  • Medites Pharma Spol. S.R.O.
  • Medtronic PLC
  • Nikkiso Co., Ltd.
  • Ningbo Tianyi Medical Appliance Co., Ltd
  • NIPRO Corporation
  • NxStage Medical, Inc.
  • Toray Medical Co., Ltd.
Product Code: SMRC22525

According to Stratistics MRC, the Global Continuous Renal Replacement Therapy (CRRT) Market is accounted for $1.31 billion in 2022 and is expected to reach $2.23 billion by 2028 growing at a CAGR of 9.3% during the forecast period. A common form of treatment for critically ill patients with acute kidney injury (AKI), particularly those with unstable hemodynamics, is continuous renal replacement therapy (CRRT). It includes the process of removing solutes from blood via hemofiltration, hemodialysis, or a combination of the two.

According to the American Hospital Association, there were 208 federal government hospitals, 625 nonfederal psychiatric hospitals, and 5,141 community hospitals in the country in 2021. The demand for CRRT systems is also rising due to the significant rise in AKI hospital admissions and the growing geriatric population, which is fueling market expansion.

Market Dynamics:

Driver:

Increase in acute kidney injury and chronic kidney diseases

The main risk factors for acute kidney injury are diabetes, hypertension, and an ageing population. Diabetes prevalence is rising quickly across the globe. As a result, the number of patients with acute kidney injury is growing along with the prevalence of diabetes. Growing awareness among medical professionals could lessen its occurrence and enhance the management of underlying diseases in the elderly population.

Restraint:

High procedural cost

People in emerging economies value affordability, so they favour lower-cost goods. Despite the high cost in developing nations, a large portion of the population cannot afford these measures because of their low purchasing power. This restricts both the developed and developing world's demand for and adoption of this therapy.

Opportunity:

Implementation of new technologies

Technology advancements in equipment design have greatly benefited the use of therapy in critically ill patients. These innovations have significantly broadened the scope of extracorporeal therapies in the ICU. Additionally, software integration is likely to emerge as a brand-new tool for cutting-edge machinery.

Threat:

Stringent healthcare regulations

Companies are vulnerable to a changing regulatory environment because they are subject to a number of existing laws and regulations, and non-compliance will likely have a negative impact on their operations, financial condition, and business. The fact that businesses' operations and goods are subject to a variety of government regulations as healthcare industry participants is a hindrance to the market's expansion.

COVID-19 Impact:

The overall impact of COVID-19 remains positive on the market. The pandemic has significantly increased the demand for renal replacement fluids on a global scale. When compared to historical US populations, the demand for RRT among COVID-19 patients has increased five times. China and Italy, for example, reported AKI rates as high as 29%, according to a study by the International Society of Nephrology 2020. Early implementation of continuous renal replacement therapy (CRRT) is crucial for reducing the incidence of AKI, which is on the rise as a result of COVID-19 infection.

The Continuous Venovenous Hemodiafiltration (CVVHDF) segment is expected to be the largest during the forecast period

The continuous venovenous hemodiafiltration (CVVHDF) segment is estimated to have a lucrative growth, due to the increase in dialysis procedures. This treatment modality results in comprehensive removal and replacement of solutes and fluids within the blood. It also includes principles of diffusion and convection, hence propelling the growth of the market.

The Adults segment is expected to have the highest CAGR during the forecast period

The adults segment is anticipated to witness the fastest CAGR growth during the forecast period, due to various regulatory approvals for adult and rise in development of novel products. Additionally, adoption of various growth strategies by various market players are creating lucrative opportunities in the segment.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to rising technological advancement, surging healthcare expenditure. This is primarily attributed to increase in number of initiatives along with enhanced investments for the overall R&D of products. Additionally, surge in focus of leading manufacturers on expanding their geographical presence is the factor driving the region growth.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period, owing to rise in geriatric population and increasing incidences of acute kidney injury. High adoption rates of new technologies in continuous renal replacement therapy and the presence of well-established healthcare infrastructure is fueling the growth of the overall regional market to a large extent.

Key players in the market

Some of the key players in Continuous Renal Replacement Therapy (CRRT) market include: Asahi Kasei Corporation, B. Braun Medical Inc., Baxter International Inc., Chongqing Shanwaishan Science and Technology Co., Ltd., Fresenius Medical Care AG & Co. KGaA, Infomed SA, Medica SpA, Medical Components, Inc., Medites Pharma Spol. S.R.O., Medtronic Plc, Nikkiso Co., Ltd., Ningbo Tianyi Medical Appliance Co., Ltd, NIPRO Corporation, NxStage Medical, Inc. and Toray Medical Co., Ltd.

Key Developments:

In February 2021, DaVita accomplished its first position by including a secure telehealth platform, DaVita Care Connect, into its home dialysis program. It is one of the various connective technologies in its suite of services designed to improve outcomes and the care experience for patients deciding to treat at home.

In December 2020, Medtronic plc announced the launch of the Carpediem Cardio-Renal Pediatric Dialysis Emergency Machine. This technique is indicated to be used in acute kidney injury or fluid overloaded patients that need hemodialysis. It is planned to supply continuous renal replacement therapy (CRRT) to patients weighing between 2.5 & 10 kg.

In April 2020, Fresenius Medical Care, a worldwide provider of dialysis products and services, has announced the release of an advisory that calls for clinical care principles for patients with advanced chronic kidney during the pandemic crisis. The advisory states that patients who need renal replacement therapy during the COVID-19 crisis should still be offered the treatment decided in consultation with their physicians.

Products Covered:

  • Dialysates and Replacement Fluids
  • Disposables
  • Hemofilters
  • Bloodline Sets & Tubes
  • CRRT Systems
  • Other Products

Modalities Covered:

  • Slow Continuous Ultra-Filtration (SCUF)
  • Continuous Venovenous Hemofiltration (CVVH)
  • Continuous Venovenous Hemodialysis (CVVHD)
  • Continuous Venovenous Hemodiafiltration (CVVHDF)

Age Groups Covered:

  • Adults
  • Pediatrics /Neonates

End Users Covered:

  • Hospitals
  • Ambulatory Centers
  • Specially Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking

Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Continuous Renal Replacement Therapy (CRRT) Market, By Product

  • 5.1 Introduction
  • 5.2 Dialysates and Replacement Fluids
  • 5.3 Disposables
  • 5.4 Hemofilters
  • 5.5 Bloodline Sets & Tubes
  • 5.6 CRRT Systems
  • 5.7 Other Products

6 Global Continuous Renal Replacement Therapy (CRRT) Market, By Modality

  • 6.1 Introduction
  • 6.2 Slow Continuous Ultra-Filtration (SCUF)
  • 6.3 Continuous Venovenous Hemofiltration (CVVH)
  • 6.4 Continuous Venovenous Hemodialysis (CVVHD)
  • 6.5 Continuous Venovenous Hemodiafiltration (CVVHDF)

7 Global Continuous Renal Replacement Therapy (CRRT) Market, By Age Group

  • 7.1 Introduction
  • 7.2 Adults
  • 7.3 Pediatrics /Neonates

8 Global Continuous Renal Replacement Therapy (CRRT) Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Ambulatory Centers
  • 8.4 Specially Clinics
  • 8.5 Other End Users

9 Global Continuous Renal Replacement Therapy (CRRT) Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Asahi Kasei Corporation
  • 11.2 B. Braun Medical Inc.
  • 11.3 Baxter International Inc.
  • 11.4 Chongqing Shanwaishan Science and Technology Co., Ltd.
  • 11.5 Fresenius Medical Care AG & Co. KGaA
  • 11.6 Infomed SA
  • 11.7 Medica SpA
  • 11.8 Medical Components, Inc.
  • 11.9 Medites Pharma Spol. S.R.O.
  • 11.10 Medtronic PLC
  • 11.11 Nikkiso Co., Ltd.
  • 11.12 Ningbo Tianyi Medical Appliance Co., Ltd
  • 11.13 NIPRO Corporation
  • 11.14 NxStage Medical, Inc.
  • 11.15 Toray Medical Co., Ltd.

List of Tables

  • Table 1 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 4 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 5 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 6 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 7 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 8 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 9 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 10 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 11 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 12 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 13 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 14 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 15 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 16 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 17 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 18 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 19 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 20 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 21 Global Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 22 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 23 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 24 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 25 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 26 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 27 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 28 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 29 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 30 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 31 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 32 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 33 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 34 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 35 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 36 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 37 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 38 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 39 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 40 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 41 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 42 North America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 43 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 44 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 45 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 46 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 47 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 48 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 49 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 50 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 51 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 52 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 53 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 54 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 55 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 56 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 57 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 58 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 59 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 60 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 61 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 62 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 63 Europe Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 64 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 65 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 66 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 67 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 68 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 69 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 70 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 71 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 72 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 73 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 74 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 75 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 76 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 77 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 78 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 79 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 80 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 81 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 82 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 83 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 84 Asia Pacific Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 85 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 86 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 87 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 88 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 89 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 90 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 91 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 92 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 93 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 94 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 95 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 96 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 97 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 98 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 99 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 100 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 101 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 102 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 103 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 104 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 105 South America Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)
  • Table 106 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Country (2020-2028) ($MN)
  • Table 107 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Product (2020-2028) ($MN)
  • Table 108 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Dialysates and Replacement Fluids (2020-2028) ($MN)
  • Table 109 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Disposables (2020-2028) ($MN)
  • Table 110 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hemofilters (2020-2028) ($MN)
  • Table 111 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Bloodline Sets & Tubes (2020-2028) ($MN)
  • Table 112 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By CRRT Systems (2020-2028) ($MN)
  • Table 113 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 114 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Modality (2020-2028) ($MN)
  • Table 115 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Slow Continuous Ultra-Filtration (SCUF) (2020-2028) ($MN)
  • Table 116 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemofiltration (CVVH) (2020-2028) ($MN)
  • Table 117 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodialysis (CVVHD) (2020-2028) ($MN)
  • Table 118 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Continuous Venovenous Hemodiafiltration (CVVHDF) (2020-2028) ($MN)
  • Table 119 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Age Group (2020-2028) ($MN)
  • Table 120 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Adults (2020-2028) ($MN)
  • Table 121 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Pediatrics /Neonates (2020-2028) ($MN)
  • Table 122 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By End User (2020-2028) ($MN)
  • Table 123 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Hospitals (2020-2028) ($MN)
  • Table 124 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Ambulatory Centers (2020-2028) ($MN)
  • Table 125 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Specially Clinics (2020-2028) ($MN)
  • Table 126 Middle East & Africa Continuous Renal Replacement Therapy (CRRT) Market Outlook, By Other End Users (2020-2028) ($MN)